CFDE Data Portal | Search ALDH1A2

	Label	Description
	ALDH1A2 Gene (Entity type)	ENSG00000128918 - aldehyde dehydrogenase 1 family member A2
	ALDH1A2 associations Collection (Entity type)	Associations for ALDH1A2_associations
	ALDH1A2 Up Gene Set (Entity type)	A Gene Set from LINCS
	ALDH1A2 Down Gene Set (Entity type)	A Gene Set from LINCS
	ALDH1A2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	UQCR11 Gene (Entity type)	ENSG00000127540 - ubiquinol-cytochrome c reductase, complex III subunit XI
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE220806 progesterone fibroblast 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	ARAP3 Gene (Entity type)	ENSG00000120318 - ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
	GSE205976 GSE205978 CEP83 knockout TIME 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS

ALDH1A2

ENSG00000128918 - aldehyde dehydrogenase 1 family member A2

ALDH1A2 associations

Associations for ALDH1A2_associations

ALDH1A2 Up

A Gene Set from LINCS

ALDH1A2 Down

A Gene Set from LINCS

ALDH1A2 associations.tsv

A file from IDG as part of the Harmonizome project

UQCR11

ENSG00000127540 - ubiquinol-cytochrome c reductase, complex III subunit XI

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE220806 progesterone fibroblast 1 v 3 human dn

A Gene Set from LINCS

ARAP3

ENSG00000120318 - ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3

GSE205976 GSE205978 CEP83 knockout TIME 1 v 4 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.